Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -168.58%-256.65M | 39.63%306.46M | -335.67%-204.98M | -206.99%-110.6M | -595.53%-247.53M | 1,454.79%374.23M | -13.17%219.47M | 234.55%86.98M | 210.85%103.38M | 70.95%-35.59M |
Net income from continuing operations | 10.60%340.58M | 24.34%130.49M | -9.99%71.64M | 15.52%82.76M | 7.60%55.68M | 12.27%307.94M | 16.64%104.95M | 11.15%79.6M | 7.94%71.64M | 11.69%51.75M |
Operating gains losses | ---- | ---- | 354.79%186K | -193.17%-1.33M | -579.96%-2.37M | ---- | ---- | -102.78%-73K | -288.03%-454K | -66.46%494K |
Depreciation and amortization | -3.81%17.22M | 11.66%5M | -14.38%3.85M | -3.66%4.34M | -8.86%4.03M | 4.71%17.9M | -9.25%4.48M | -17.44%4.49M | 24.15%4.5M | 43.16%4.43M |
Deferred tax | 36.79%-14.12M | -44.86%-24.77M | 138.51%1.24M | 666.72%11.07M | -1,902.41%-1.66M | -7,500.34%-22.35M | -1,186.90%-17.1M | 82.64%-3.21M | -697.14%-1.95M | -100.49%-83K |
Other non cash items | -171.97%-23.69M | -165.07%-8.23M | -36.13%5.95M | -452.60%-21.78M | -92.35%366K | 283.07%32.92M | 2,469.11%12.64M | 384.37%9.31M | -4.38%6.18M | -2.62%4.79M |
Change In working capital | -2,609.56%-595.42M | 76.50%195.31M | -4,111.77%-292.97M | -1,082.33%-190.72M | -208.92%-307.04M | 107.10%23.73M | -29.87%110.66M | 94.40%-6.96M | 111.34%19.42M | 49.43%-99.39M |
-Change in receivables | -120.88%-2.63M | -260.79%-3.93M | 281.72%3.42M | -324.82%-4.79M | -73.18%2.66M | 206.46%12.62M | 132.97%2.44M | 75.40%-1.88M | -34.51%2.13M | 19,562.75%9.93M |
-Change in inventory | -140.20%-148.02M | 918.30%346.22M | -185.14%-161.24M | -1,076.10%-160.76M | -210.09%-172.23M | 80.22%-61.62M | -74.75%34M | 63.94%-56.55M | 113.29%16.47M | 66.42%-55.54M |
-Change in prepaid assets | -797.10%-209.49M | -1,425.38%-90.41M | -1,107.49%-66.73M | -329.49%-33.09M | -228.95%-19.26M | 183.82%30.05M | -142.19%-5.93M | 329.97%6.62M | 210.30%14.42M | 143.99%14.94M |
-Change in payables and accrued expense | 82.98%41.63M | 14.18%92.98M | -106.89%-3.17M | 381.67%69.48M | -46.98%-117.66M | -65.40%22.75M | 114.72%81.43M | 11.74%46.03M | -779.67%-24.67M | -657.32%-80.05M |
-Change in other current assets | -21,426,400.00%-214.27M | -2,300.69%-206.17M | -834.25%-1.87M | -226.81%-19.58M | 287.89%13.35M | 99.97%-1K | -259.18%-8.59M | -98.93%254K | 185.67%15.44M | 49.41%-7.1M |
-Change in other current liabilities | 1.75%-6.87M | 3.76%-1.67M | 4.54%-1.66M | 1.60%-1.73M | -2.83%-1.81M | -21.95%-6.99M | -3.41%-1.73M | -7.54%-1.74M | -16.31%-1.75M | -89.47%-1.76M |
-Change in other working capital | -307.19%-55.78M | 545.35%58.28M | -20,205.54%-61.72M | -1,434.97%-40.25M | -159.83%-12.09M | 184.05%26.92M | 135.93%9.03M | 101.52%307K | 82.66%-2.62M | -28.81%20.21M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -168.58%-256.65M | 39.63%306.46M | -335.67%-204.98M | -206.99%-110.6M | -595.53%-247.53M | 1,454.79%374.23M | -13.17%219.47M | 234.55%86.98M | 210.85%103.38M | 70.95%-35.59M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -4,843.62%-221.67M | -4,938.62%-24.14M | -642.60%-7.83M | -132.50%-3.7M | -13,577.28%-186.01M | 18.83%-4.48M | 68.05%-479K | 58.68%-1.05M | -192.46%-1.59M | -46.24%-1.36M |
Net PPE purchase and sale | -473.47%-25.31M | -458.11%-3.96M | -2,225.07%-17.53M | -12.95%-1.8M | -49.12%-2.03M | 18.15%-4.41M | 40.87%-709K | 67.40%-754K | -68.18%-1.59M | -45.45%-1.36M |
Net business purchase and sale | -280,412.86%-196.36M | -8,873.04%-20.18M | 3,334.67%9.7M | ---1.9M | ---183.98M | 46.56%-70K | 176.67%230K | -26.05%-300K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -4,843.62%-221.67M | -4,938.62%-24.14M | -642.60%-7.83M | -132.50%-3.7M | -13,577.28%-186.01M | 18.83%-4.48M | 68.05%-479K | 58.68%-1.05M | -192.46%-1.59M | -46.24%-1.36M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 224.61%269.69M | -418.18%-175.34M | 409.09%149.02M | 294.32%143.11M | 351.78%152.91M | -247.27%-216.42M | -89.35%-33.84M | -148.44%-48.21M | -218.45%-73.64M | -2,045.85%-60.73M |
Net issuance payments of debt | 358.70%351.48M | -578.02%-170.37M | 900.37%161.36M | 547.89%180.59M | 457.98%179.9M | -166.94%-135.86M | -146.52%-25.13M | -120.19%-20.16M | -138.46%-40.32M | -695.87%-50.26M |
Net common stock issuance | -6,201.55%-20.29M | ---1.16M | ---4.82M | -1,096.89%-3.85M | ---10.46M | ---322K | --0 | --0 | ---322K | --0 |
Net preferred stock issuance | --0 | --0 | ---- | ---- | ---- | ---11.08M | --0 | ---- | ---- | ---- |
Cash dividends paid | -1.98%-13.5M | 0.00%-3.38M | -116.83%-6.75M | --0 | 0.00%-3.38M | 3.29%-13.24M | 2.17%-3.38M | 9.79%-3.11M | 50.27%-3.38M | ---3.38M |
Net other financing activities | 14.18%-48M | 91.77%-439K | 94.50%-762K | -13.50%-33.63M | -85.48%-13.17M | -32.17%-55.92M | -26.18%-5.34M | -545.87%-13.86M | 17.43%-29.63M | -33.62%-7.1M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 224.61%269.69M | -418.18%-175.34M | 409.09%149.02M | 294.32%143.11M | 351.78%152.91M | -247.27%-216.42M | -89.35%-33.84M | -148.44%-48.21M | -218.45%-73.64M | -2,045.85%-60.73M |
Net cash flow | ||||||||||
Beginning cash position | 38.80%548.46M | -35.91%232.85M | -8.89%296.63M | -9.96%267.82M | 38.80%548.46M | 40.45%395.13M | 124.63%363.3M | 151.63%325.59M | 84.73%297.45M | 40.45%395.13M |
Current changes in cash | -236.07%-208.63M | -42.22%106.98M | -269.14%-63.78M | 2.38%28.81M | -187.30%-280.64M | 34.72%153.33M | -20.67%185.16M | 16.61%37.71M | 188.99%28.14M | 18.81%-97.68M |
End cash Position | -38.04%339.83M | -38.04%339.83M | -35.91%232.85M | -8.89%296.63M | -9.96%267.82M | 38.80%548.46M | 38.80%548.46M | 124.63%363.3M | 151.63%325.59M | 84.73%297.45M |
Free cash flow | -176.33%-281.99M | 38.41%302.55M | -358.53%-222.53M | -210.48%-112.42M | -575.17%-249.61M | 1,213.88%369.45M | -13.10%218.6M | 228.39%86.07M | 207.99%101.75M | 70.05%-36.97M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |